ROHTO V ARCTIC OTC
Generic Name and Formulations:
Tetrahydrozoline HCl 0.05%, hypromellose 0.35%; oph. soln; contains benzalkonium chloride, menthol.
Indications for ROHTO V ARCTIC:
Ocular redness and dryness.
Adults and Children:
1–2 drops in affected eye(s) up to 4 times daily.
Narrow angle glaucoma. Discontinue if eye pain, vision changes, or severe redness or irritation occurs. Remove contact lenses before using.
Vasoconstrictor + lubricant.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- ADHD Medications Compared for Efficacy, Tolerability in Children and Adults
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation